Coupang (CPNG) insider files Form 144 for 75,350 shares ($2.10M)

Coupang insider Gaurav Anand submitted a Form 144 to notify a proposed sale of 75,350 common shares, with an aggregate market value of $2,096,990.50, to be executed on or about 08/11/2025 through Morgan Stanley Smith Barney LLC on the NYSE.

Rhea-AI Filing Summary

Coupang insider Gaurav Anand submitted a Form 144 to notify a proposed sale of 75,350 common shares, with an aggregate market value of $2,096,990.50, to be executed on or about 08/11/2025 through Morgan Stanley Smith Barney LLC on the NYSE. The filing shows those shares were acquired by previously exercised stock options on 10/21/2020 (12,100 shares) and 12/13/2021 (63,250 shares), with payment in cash. The notice also reports recent May 2025 sales by the same person: 175,000 shares for $4,919,635.00 and 75,350 shares under a 10b5-1 plan for $1,966,921.33. The proposed sale represents approximately 0.0045% of the 1,665,262,233 shares outstanding reported in the filing, and the filer affirms no undisclosed material adverse information.

Positive

• 10b5-1 sale is documented, indicating use of a pre-established trading plan for at least one transaction
• Acquisition details are explicit (dates and that payment was cash for exercised options), improving transparency

Negative

• Insider disposed of shares in May 2025 (175,000 and 75,350 shares), generating stated gross proceeds
• Proposed additional sale of 75,350 shares announced for 08/11/2025

Insights

Financial Analyst

TL;DR: Insider sales are disclosed but represent a very small portion of outstanding shares; limited likely market impact.

The filing notifies a proposed sale of 75,350 shares valued at $2,096,990.50 and records May 2025 disposals of 175,000 and 75,350 shares generating stated proceeds. Given the 1,665,262,233 shares outstanding in the filing, the proposed sale equals roughly 0.0045% of outstanding stock, so the direct supply shock to the market is minimal. The disclosure is clear on acquisition dates and cash payment for exercised options, allowing precise tracking of insider liquidity events.

Corporate Governance Expert

TL;DR: Form 144 plus a noted 10b5-1 sale point to routine, pre-scheduled insider selling and formal compliance with disclosure rules.

The filing identifies a broker (Morgan Stanley Smith Barney LLC), an approximate sale date (08/11/2025), and explicitly references a 10b5-1 sale executed in May 2025. Those details indicate the filer followed recognized procedures for reporting and executing insider sales. The signature representation that no undisclosed material adverse information exists is standard and included in the notice.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Coupang insider Gaurav Anand disclose in the Form 144 (CPNG)?

The filing notifies a proposed sale of 75,350 common shares valued at $2,096,990.50, to be sold on or about 08/11/2025 through Morgan Stanley Smith Barney LLC on the NYSE.

How were the shares being sold by the filer acquired?

The shares were acquired by previously exercised stock options on 10/21/2020 (12,100 shares) and 12/13/2021 (63,250 shares), with payment in cash.

Has the filer sold shares recently before this Form 144?

Yes. The filing reports sales in May 2025: 175,000 shares for $4,919,635.00 (05/29/2025) and 75,350 shares via a 10b5-1 plan for $1,966,921.33 (05/12/2025).

What portion of outstanding shares does the proposed sale represent?

The filing lists 1,665,262,233 shares outstanding; the proposed sale of 75,350 shares is approximately 0.0045% of that total.

Which broker is handling the proposed sale?

The broker named in the filing is Morgan Stanley Smith Barney LLC, 1 New York Plaza, 8th Floor, New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/11/2025 - 04:22 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001849248
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COUPANG, INC
SEC File Number	001-40115
Address of Issuer	720 Olive Way, Suite 600 SEATTLE WASHINGTON 98101
Phone	206-333-3839
Name of Person for Whose Account the Securities are To Be Sold	GAURAV ANAND
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	75350	2096990.50	1665262233	08/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/21/2020	Previously Exercised Stock Options	Issuer			12100	10/21/2020	Cash
Common	12/13/2021	Previously Exercised Stock Options	Issuer			63250	12/13/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
GAURAV ANAND 720 Olive Way, Suite 600 SEATTLE WA 98101	Common	05/29/2025	175000	4919635.00
10b5-1 Sales for GAURAV ANAND 720 Olive Way, Suite 600 SEATTLE WA 98101	Common	05/12/2025	75350	1966921.33

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a stock trading plan adopted on December 8, 2024 in accordance with SEC guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended and such plan is intended to comply with Rule 10b5-1(c).
Date of Notice	08/11/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/08/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gaurav Anand
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)